Oligoadenylate synthetase/protein kinase R pathways and αβ TCR+ T cells are required for adenovirus vector: IFN-γ inhibition of herpes simplex virus-1 in cornea

Journal of Immunology

Volumn 178, Issue 8, 2007, Pages 5166-5172

  Austin, Bobbie Ann ^a,d   Halford, William P ^b   Williams, Bryan R G ^c   Carr, Daniel J J ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b MONTANA STATE UNIVERSITY   (United States)

^c MONASH MEDICAL CENTRE   (Australia)

^d NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; DOUBLE STRANDED RNA; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INTERFERON; OLIGOADENYLATE SYNTHETASE; PROTEIN KINASE R; SYNTHETASE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVITY; EVALUATION; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TRANSGENE; TRIGEMINUS GANGLION; VIRUS LOAD; VIRUS REPLICATION;

EID: 34247123758     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.8.5166     Document Type: Article

References (79)

1. Bach, E. A., M. Aguet, and R. D. Schreiber. 1997. The IFNγ receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15: 563-591.
2. Farrar, M. A., and R. D. Schreiber. 1993. The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11: 571-611.
3. 2-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Mol. Cell Biol. 20: 617-627.
4. Lee, S. B., R. Bablanian, and M. Esteban. 1996. Regulated expression of the interferon-induced protein kinase p68 (PKR) by vaccinia virus recombinants inhibits the replication of vesicular stomatitis virus but not that of poliovirus. J. Interferon Cytokine Res. 16: 1073-1078.
5. Khabar, K. S., M. Dhalla, Y. Siddiqui, A. Zhou, M. N. Al-Ahdal, S. D. Der, R. H. Silverman, and B. R. Williams. 2000. Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes. J. Interferon Cytokine Res. 20: 653-659.
6. Theetasurakarn, S., and S. Ubol. 1998. Apoptosis induction in brain during the fixed strain of rabies virus infection correlates with onset and severity of illness. J. Neurovirol. 4: 407-414.
7. Díaz-Guerra, M., C. Rivas, and M. Esteban. 1997. Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication. Virology 227: 220-228.
8. Patterson, C. E., D. M. Lawrence, L. A. Echols, and G. F. Rall. 2002. Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and γ interferon dependent. J. Virol. 76: 4497-4506.
9. Pavlovic, J., H. A. Arzet, H. P. Hefti, M. Frese, D. Rost, B. Ernst, E. Kolb, P. Staeheli, and O. Haller. 1995. Enhanced virus resistance of transgenic mice expressing the human MxA protein. J. Virol. 69: 4506-4510.
10. Staeheli, P., and J. Pavlovic. 1991. Inhibition of vesicular stomatitis virus mRNA synthesis by human MxA protein. J. Virol. 65: 4498-4501.
11. Komatsu, T., Z. Bi, and C. S. Reiss. 1996. Interferon-γ induced type 1 nitric oxide synthase activity inhibits viral replication in neurons. J. Neuroimmunol. 68: 101-108.
12. Lowenstein, C. J., S. L. Hill, A. Lafond-Walker, J. Wu, G. Allen, M. Landavere, N. R. Rose, and A. Herskowitz. 1996. Nitric oxide inhibits viral replication in murine myocarditis. J. Clin. Invest. 97: 1837-1843.
13. Detels, R., J. A. Brody, J. McNew, and A. H. Edgar. 1973. Further epidemiological studies of subacute sclerosing panencephalitis. Lancet 2: 11-14.
14. Chester, D. A., and C. S. Reiss. 2002. The role of IFN-γ in immune responses to viral infections of the central nervous system. Cytokine Growth Factor Rev. 13: 441-454.
15. Austin, B. A., W. Halford, R. H. Silverman, B. R. Williams, and D. J. Can. 2006. OAS and PKR are not required for the antiviral effect of Ad:IFN-γ against acute HSV-1 in primary trigeminal ganglia cultures. J. Interferon Cytokine Res. 26: 220-225.
16. Al-Khatib, K., B. R. Williams, R. H. Silverman, W. Halford, and D. J. Carr. 2004. Distinctive roles for 2′,5′-oligoadenylate synthetases and double-stranded RNA-dependent protein kinase R in the in vivo antiviral effect of an adenoviral vector expressing murine IFN-β. J. Immunol. 172: 5638-5647.
17. Al-khatib, K., B. R. Williams, R. H. Silverman, W. Halford, and D. J. Carr. 2003. The murine double-stranded RNA-dependent protein kinase PKR and the murine 2′,5′-oligoadenylate synthetase-dependent RNase L are required for IFN-β-mediated resistance against herpes simplex virus type 1 in primary trigeminal ganglion culture. Virology 313: 126-135.
18. Noisakran, S., and D. J. Carr. 2001. Topical application of the cornea post-infection with plasmid DNA encoding interferon-α but not recombinant interferon-αA reduces herpes simplex virus type 1-induced mortality in mice. J. Neuroimmunol. 121: 49-58.
19. Vollstedt, S., S. Arnold, C. Schwerdel, M. Franchini, G. Alber, J. P. Di Santo, M. Ackermann, and M. Suter. 2004. Interplay between αβ and γ interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1. J. Virol. 78: 3846-3850.
20. Pierce, A. T., J. DeSalvo, T. P. Foster, A. Kosinski, S. K. Weller, and W. P. Halford. 2005. β Interferon and γ interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells. J. Gen. Virol. 86: 2421-2432.
21. Halford, W. P., K. J. Halford, and A. T. Pierce. 2005. Mathematical analysis demonstrates that interferons-β and -γ interact in a multiplicative manner to disrupt herpes simplex virus replication. J. Theor. Biol. 234: 439-454.
22. Neumann-Haefelin, D., R. Sundmacher, H. Frey, and W. Merk. 1985. Recombinant HuIFN-γ prevents herpes simplex keratitis in African green monkeys: demonstration of synergism with recombinant HuIFN-α2. Med. Microbiol. Immunol. 174: 81-86.
23. Muller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921.
24. Zhou, A., J. Paranjape, T. L. Brown, H. Nie, S. Naik, B. Dong, A. Chang, B. Trapp, R. Fairchild, C. Colmenares, and R. H. Silverman. 1997. Interferon action and apoptosis are defective in mice devoid of 2′,5′- oligoadenylate-dependent RNase L. EMBO J. 16: 6355-6363.
25. Shimeld, C., J. L. Whiteland, S. M. Nicholls, E. Grinfeld, D. L. Easty, H. Gao, and T. J. Hill. 1995. Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. J. Neuroimmunol. 61: 7-16.
26. Manickan, E., and B. T. Rouse. 1995. Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse-models. J. Virol. 69: 8178-8179.
27. Cantin, E. M., D. R. Hinton, J. Chen, and H. Openshaw. 1995. γ Interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J. Virol. 69: 4898-4905.
28. Shimeld, C., J. L. Whiteland, N. A. Williams, D. L. Easty, and T. J. Hill. 1997. Cytokine production in the nervous system of mice during acute and latent infection with herpes simplex virus type 1. J. Gen. Virol. 78: 3317-3325.
29. Feduchi, E., M. A. Alonso, and L. Carrasco. 1989. Human γ interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus. J. Virol. 63: 1354-1359.
30. Garvey, T. L., K. D. Dyer, J. A. Ellis, C. A. Bonville, B. Foster, C. Prussin, A. J. Easton, J. B. Domachowske, and H. F. Rosenberg. 2005. Inflammatory responses to pneumovirus infection in IFN-αβ R gene-deleted mice. J. Immunol. 175: 4735-4744.
31. Yang, Y. L., L. F. Reis, J. Pavlovic, A. Aguzzi, R. Schafer, A. Kumar, B. R. Williams, M. Aguet, and C. Weissmann. 1995. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14: 6095-6106.
32. Halford, W. P., B. M. Gebhardt, and D. J. Carr. 1996. Mechanisms of herpes simplex virus type 1 reactivation. J. Virol. 70: 5051-5060.
33. Kolls, J., K. Peppel, M. Silva, and B. Beutler. 1994. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 91: 215-219.
34. Lei, D., J. R. Lancaster, Jr., M. S. Joshi, S. Nelson, D. Stoltz, G. J. Bagby, G. Odom, J. E. Shellito, and J. K. Kolls. 1997. Activation of alveolar macrophages and lung host defenses using transfer of the interferon-γ gene. Am. J. Physiol. 272: L852-L859.
35. Al-Khatib, K., B. R. Williams, R. H. Silverman, W. Halford, and D. J. Carr. 2005. Dichotomy between survival and lytic gene expression in RNase L- and PKR-deficient mice transduced with an adenoviral vector expressing murine IFN-β following ocular HSV-1 infection. Exp. Eye Res. 80: 167-173.
36. Whitcher, J. P., M. Srinivasan, and M. P. Upadhyay. 2001. Corneal blindness: a global perspective. Bull World Health Organ. 79: 214-221.
37. Mitchell, W. J., P. Gressens, J. R. Martin, and R. DeSanto. 1994. Herpes simplex virus type 1 DNA persistence, progressive disease and transgenic immediate early gene promoter activity in chronic corneal infections in mice. J. Gen. Virol. 75: 1201-1210.
38. Nesburn, A. B. 1975. Recurrence in ocular herpes simplex infection. Int. Ophthalmol Clin. 15: 101-110.
39. Carr, D. J., K. Al-khatib, C. M. James, and R. Silverman. 2003. Interferon-β suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway. J. Neuroimmunol. 141: 40-46.
40. Samuel, C. E. 2001. Antiviral actions of interferons. Clin. Microbiol. Rev. 14: 778-809.
41. Sen, G. C. 2001. Viruses and interferons. Annu. Rev. Microbiol. 55: 255-281.
42. Al-Khatib, K., B. R. Williams, R. H. Silverman, W. P. Halford, and D. J. Carr. 2002. Absence of PKR attenuates the anti-HSV-1 activity of an adenoviral vector expressing murine IFN-β. J. Interferon Cytokine Res. 22: 861-871.
43. Austin, B. A., C. James, R. H. Silverman, and D. J. Carr. 2005. Critical role for the oligoadenylate synthetase/RNase L pathway in response to IFN-β during acute ocular herpes simplex virus type 1 infection. J. Immunol. 175: 1100-1106.
44. Carr, D. J., L. A. Veress, S. Noisakran, and I. L. Campbell. 1998, Astrocyte-targeted expression of IFN-α1 protects mice from acute ocular herpes simplex virus type 1 infection. J. Immunol. 161: 4859-4865.
45. Kimura, T., Y. Murata, T. Yamaguchi, and K. Okumura. 1989. Immunopathological analysis of T and non-T cell involvement in corneal inflammation caused by HSV type-1 infection. Nippon Ganka Gakkai Zasshi 93: 124-131.
46. Bouley, D. M., S. Kanangat, W. Wire, and B. T. Rouse. 1995. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-γ knockout mice. J. Immunol. 155: 3964-3971.
47. He, J., H. Ichimura, T. Iida, M. Minami, K. Kobayashi, M. Kita, C. Sotozono, Y. I. Tagawa, Y. Iwakura, and J. Imanishi. 1999. Kinetics of cytokine production in the cornea and trigeminal ganglion of C57BL/6 mice after corneal HSV-1 infection. J. Interferon Cytokine Res. 19: 609-615.
48. Sainz, B., Jr., and W. P. Halford. 2002. αβ Interferon and γ interferon synergize to inhibit the replication of herpes simplex virus type 1. J. Virol. 76: 11541-11550.
49. + T-cell type 1 and type 2 cytokines in the HSV-1 infected cornea. Graefes Arch. Clin. Exp. Ophthalmol. 237: 399-406.
50. Geiger, K. D., T. C. Nash, S. Sawyer, T. Krahl, G. Patstone, J. C. Reed, S. Krajewski, D. Dalton, M. J. Buchmeier, and N. Sarvetnick. 1997. Imerferon-γ protects against herpes simplex virus type 1-mediated neuronal death. Virology 238: 189-197.
51. + T cells in herpetic stromal keratitis. J. Immunol. 173: 7575-7583.
52. Banerjee, K., P. S. Biswas, and B. T. Rouse. 2005. Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis. J. Leukocyte Biol. 77: 24-32.
53. Banerjee, K., S. Deshpande, M. Zheng, U. Kumaraguru, S. P. Schoenberger, and B. T. Rouse. 2002. Herpetic stromal keratitis in the absence of viral antigen recognition. Cell. Immunol. 219: 108-118.
54. Hendrieks, R. L., T. M. Tumpey, and A. Finnegan. 1992. IFN-γ and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. J. Immunol. 149: 3023-3028.
55. Brandt, C. R., and C. A. Salkowski. 1992. Activation of NK cells in mice following corneal infection with herpes simplex virus type-1. Invest. Ophthalmol. Vis. Sci. 33: 113-120.
56. Cantin, E., B. Tanamachi, and H. Openshaw. 1999. Role for interferon in control of herpes simplex virus type 1 reactivation. J. Virol. 73: 3418-3423.
57. Carr, D. J. 1998. Increased levels of IFN-γ in the trigeminal ganglion correlate with protection against HSV-1-induced encephalitis following subcutaneous administration with androstenediol. J. Neuroimmunol. 89: 160-167.
58. Costa-Pereira, A. P., T. M. Williams, B. Strobl, D. Watling, J. Briscoe, and I. M. Kerr. 2002. The antiviral response to γ interferon. J. Virol. 76: 9060-9068.
59. Decman, V., P. R. Kinchington, S. A. Harvey, and R. L. Hendricks. 2005. γ Interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression. J. Virol. 79: 10339-10347.
60. Glenn, J. A., J. B. Sonceau, H. J. Wynder, and W. E. Thomas. 1993. Histochemical evidence for microglia-like macrophages in the rat trigeminal ganglion. J. Anat. 183: 475-481.
61. + T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J. Exp. Med. 191: 1459-1466.
62. Liu, T., Q. Tang, and R. L. Hendricks. 1996. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J. Virol. 70: 264-271.
63. Xia, L. K., J. S. Zhang, X. L. Chen, and A. Y. Wang. 2005. Cytokine expression in murine cornea tissue during recurrent herpetic stromal keratitis. Zhonghua Yen Ke Za Zhi 41: 403-408.
64. Seo, S. K., B. M. Gebhardt, H. Y. Lim, S. W. Rang, S. Higaki, E. D. Varnell, J. M. Hill, H. E. Kaufman, and B. S. Kwon. 2001. Murine keratocytes function as antigen-presenting cells. Eur. J. Immunol. 31: 3318-3328.
65. Hendricks, R. L. 1997. An immunologist's view of herpes simplex keratitis: Thygeson Lecture 1996, presented at the Ocular Microbiology and Immunology Group meeting, October 26, 1996. Cornea 16: 503-506.
66. James, D. C., R. B. Freedman, M. Hoare, O. W. Ogonah, B. C. Rooney, O. A. Larionov, V. N. Dobrovolsky, O. V. Lagutin, and N. Jenkins. 1995. N-glycosylation of recombinant human interferon-γ produced in different animal expression systems. Biotechnology 13: 592-596.
67. James, D. C., M. H. Goldman, M. Hoare, N. Jenkins, R. W. Oliver, B. N. Green, and R. B. Freedman. 1996. Posttranslational processing of recombinant human interferon-γ in animal expression systems. Protein Sci. 5: 331-340.
68. Hooker, A. D., N. H. Green, A. J. Baines, A. T. Bull, N. Jenkins, P. G. Strange, and D. C. James. 1999. Constraints on the transport and glycosylation of recombinant IFN-γ in Chinese hamster ovary and insect cells. Biotechnol. Bioeng. 63: 559-572.
69. Cencic, A., F. LeFevre, S. Koren, and C. La Bonnardiere. 1999. Tetracycline-controlled expression of glycosylated porcine inteiferon-γ in mammalian cells. Anim. Biotechnol. 10: 63-79.
70. Laurent, A. M., J. J. Madjar, and A. Greco. 1998. Translational control of viral and host protein synthesis during the course of herpes simplex virus type 1 infection: evidence that initiation of translation is the limiting step. J. Gen. Virol. 79: 2765-2775.
71. Lortat-Jacob, H., P. Esterre, and J. A. Grimaud. 1994. Interferon-γ, an antifibrogenic cytokine which binds to heparan sulfate. Pathol. Res. Pract. 190: 920-922.
72. WuDunn, D., and P. G. Spear. 1989. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63: 52-58.
73. Wuest, T., B. A. Austin, S. Uematsu, M. Thapa, S. Akira, and D. J. Carr. 2006. Intact TRL 9 and type I interferon signaling pathways are required to augment HSV-1 induced corneal CXCL9 and CXCL10. J. Neuroimmunol. 179: 46-52.
74. Li, X. Y., L. T. D'Orazio, and J. Y. Niederkom. 1996. Role of Th1 and Th2 cells in anterior chamber-associated immune deviation. Immunology 89: 34-40.
75. Garside, P., and A. M. Mowat. 1995. Polarization of Th-cell responses: a phylogenetic consequence of nonspecific immune defence. Immunol. Today 16: 220-223.
76. Mosmann, T. R., and K. W. Moore. 1991. The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol. Today 12: A49-A53.
77. Kielty, D., S. W. Cousins, and S. S. Atherton. 1987. HSV-1 retinitis and delayed hypersensitivity in DBA/2 and C57BL/6 mice. Invest. Ophthalmol. Vis. Sci. 28: 1994-1999.
78. Geiger, K., and N. Sarvetnick. 1994. Local production of IFN-γ abrogates the intraocular immune privilege in transgenic mice and prevents the induction of ACAID. J. Immunol. 153: 5239-5246.
79. Thomas, J., S. Gangappa, S. Kanangat, and B. T. Rouse. 1997. On the essential involvement of neutrophils in the immunopathological disease: herpetic stromal keratitis. J. Immunol. 158: 1383-1391.